News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

Migraine

Latest News

Latest Videos

Improving Use of Telemedicine in Minority Communities: Aarushi Suneja, MD; Zubair Ahmed, MD

Improving Use of Telemedicine in Minority Communities: Aarushi Suneja, MD; Zubair Ahmed, MD

Raising Awareness for Pediatric Migraine: Valentina Popova, MD

Raising Awareness for Pediatric Migraine: Valentina Popova, MD

Advantages and Safety Profile of INP104: Sheena K. Aurora, MD

The Broad Receptor Profile of DHE: Sheena K. Aurora, MD

Potential Layered Migraine Treatment Approaches to Research: Andrew Blumenfeld, MD

Potential Layered Migraine Treatment Approaches to Research: Andrew Blumenfeld, MD

Exploring New Therapy Combinations to Treat Migraine: Richard B. Lipton, MD

Exploring New Therapy Combinations to Treat Migraine: Richard B. Lipton, MD

The Mini-Prevention Concept in Migraine Care: Deena Kuruvilla, MD

The Mini-Prevention Concept in Migraine Care: Deena Kuruvilla, MD

TEAM study of e-TNS for the Acute Treatment of Migraine: Deena Kuruvilla, MD

TEAM study of e-TNS for the Acute Treatment of Migraine: Deena Kuruvilla, MD

Determining Migraine Treatment Eligibility: Stephanie J. Nahas, MD

Determining Migraine Treatment Eligibility: Stephanie J. Nahas, MD

Underutilization of Preventive Migraine Treatments: Stephanie J. Nahas, MD

Underutilization of Preventive Migraine Treatments: Stephanie J. Nahas, MD

CME Content

Increasing Awareness of Therapeutic Options for Thymidine Kinase 2 Deficiency (TK2d)

In-Person Event

Increasing Awareness of Therapeutic Options for Thymidine Kinase 2 Deficiency (TK2d)

October 16, 2026

Primary Care Education in Nashville

In-Person + Virtual Event

Primary Care Education in Nashville

October 20-21, 2026

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD, FAAN, FANA

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Anne M. Connolly, MD, FAAN; Amy Moore, PhD

Show Me the Data™: Turning Molecular Drivers Into Precision Care for CNS Tumors

In-Person + Virtual Event

Show Me the Data™: Turning Molecular Drivers Into Precision Care for CNS Tumors

November 12, 2026

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Jessica Oswald, MD, MPH; Jeremy A. Adler, DMSc, PA-C; Amanda Nasser, MS, NP

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

James F. Howard Jr, MD, FAAN; Katherine Ruzhansky, MD, MS

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA, FASCO; Girish Dhall, MD

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Millie Das, MD; Wade Iams, MD, MSCI; Ruham Nasany, MD

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Abigail Schwaede, MD; Alexis Lizarraga, MD, MS

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD

How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients

How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients

Michael Levy, MD, PhD; Jeffrey L. Bennett, MD, PhD; Eoin P. Flanagan, MB, BCh

More News

Advantages of Atogepant in Ever-Growing CGRP Market: Lawrence Severt, MD, PhD

ByLawrence Severt, MD, PhD

May 4th 2021

The director at AbbVie highlighted where atogepant stands among the increasing treatment landscape of anti-calcitonin gene-related peptide options within the migraine treatment landscape.

Atogepant’s Impact on Patient-Reported Outcomes: Lawrence Severt, MD, PhD

April 28th 2021

The director at AbbVie discussed a subgroup analysis of the phase 3 ADVANCE study of atogepant in patients with migraine and its benefit on patient-reported outcome measures.

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Solengepras Meets Primary Endpoint in Phase 3 ARISE Trial of Parkinson Disease

CSF Biomarkers Identify Shared LRRK2 Pathway Activation in Sporadic and LRRK2-Associated Parkinson Disease

Advanced Therapies in Parkinson Disease: Matching the Right Treatment to the Right Patient

Beyond MRI: The Role of Serum Biomarkers in Multiple Sclerosis

Frontotemporal Dementia Diagnosis, Head Impacts, and Emerging Treatment Approaches